M&A Deal Summary

Advent International Acquires Suven Pharma

On December 26, 2022, private equity firm Advent International acquired life science company Suven Pharma

Acquisition Highlights
  • This is Advent International’s 20th transaction in the Life Science sector.
  • This is Advent International’s 14th transaction in India.

M&A Deal Summary
Date 2022-12-26
Target Suven Pharma
Sector Life Science
Buyer(s) Advent International
Deal Type Going Private
Advisor(s) Barclays Investment Bank (Financial)

Target

Suven Pharma

Hyderabad, India
Suven Pharma is a biopharmaceutical company that develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. Suven Pharma was formed in 2018 and is based in Hyderabad, India.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Advent International

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1984
PE ASSETS 76.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 327 of 340
Sector (Life Science) 20 of 21
Type (Going Private) 18 of 19
Country (India) 14 of 15
Year (2022) 14 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-16 Maxar

Westminster, Colorado, United States

Maxar is a global communications and information company providing operational solutions to commercial and government organizations worldwide. Maxar business is focused on markets and customers with strong repeat business potential, primarily in the Communications sector and the Surveillance and Intelligence sector. In addition, the Company conducts a significant amount of advanced technology development. Maxar was founded in 1969 and is based in Westminster, Colorado.

Buy $6.4B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-02 Thesis

Chesterfield, Missouri, United States

Thesis is a provider of cloud-based, next generation university administration software that offers student information management solutions for higher education institutions in the UK, Canada and the US, focusing on the use of best-practice standards, automation, and process simplification to free faculty and staff from administrative work so they can concentrate on their core mission. Thesis was founded in 2021 and is based in Chesterfield, Missouri.

Sell -
Mergr

Product

Company

Legal